Registry of Lobbyists
Version 2 of 2 (1999-01-21 to 2000-02-29) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
RHONE-POULENC RORER CANADA INC.
4707, RUE LEVY SAINT-LAURENT, QC H4R 2P9 Canada |
| Telephone number: | 514-856-8349 |
| Fax number: | 514-856-8715 |
| Responsible officer name and position during the period of this registration: | BENOIT GRAVEL, VICE-PRISIDENT, AFFAIRES EXTERIEUR ES |
| Description of activities: | RHONE-POULENC RORER CANADA INC. DEVELOPPE ET MET EN MARCHE DES PRODUITS PHARMACEUTIQUES.LES AXES THERAPEUTIQUES SONT LE SYSTEME NERVEUX CENTRAL, INFECTIOLOGIE, CANCER, ET RESPIRATOIRE. |
| The client is a subsidiary of the following parent companies: |
RHONE-POULENC RORER SA
20, AVENUE RAYMOND ARON ANTONY CEDEX F-92165 France |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB) |
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
| Subject Matter: Areas of Concern: | Consumer Issues, Health, Intellectual Property, Science and Technology |
| Subject Matter: Particulars: | LOI SUR LES BREVETS [ PATENT ACT]; ACTIVITES AVEC LE CONSEIL D'EXAMEN DES PRIX DES MEDICAMENTS BREVETES; ACTIVITES AVEC LA DGPS |